Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

被引：19

作者：

Wang, Xiaohui ^{[1
]}

Li, Xiaolei ^{[1
]}

Fu, Xiaoyu ^{[2
]}

Bai, Miaomiao ^{[1
]}

Li, Xiang ^{[1
]}

Mei, Qian ^{[1
]}

Nie, Jing ^{[1
]}

Wu, Zhiqiang ^{[1
]}

Han, Weidong ^{[1
]}

机构：

[1] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing 100853, Peoples R China

[2] Chinese Peoples Liberat Army Gen Hosp, Obstet & Gynecol, Beijing 100853, Peoples R China

来源：

CURRENT PROTEIN & PEPTIDE SCIENCE | 2015年 / 16卷 / 04期

基金：

中国国家自然科学基金;

关键词：

OCSCs; ovarian cancer; chemoresistance; therapeutic target; MULLERIAN-INHIBITING SUBSTANCE; TUMOR-INITIATING CELLS; PULSED DENDRITIC CELLS; ACUTE MYELOID-LEUKEMIA; SIDE-POPULATION; ALDEHYDE DEHYDROGENASE; BREAST-CANCER; MALIGNANT GLIOMA; IMMUNE-RESPONSE; PROSTATE-CANCER;

D O I：

10.2174/138920371604150429151457

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Tumor recurrence followed by chemoresistance is a major cause of the poor survival rates for ovarian cancer. Despite advances in ovarian cancer chemotherapies and increased knowledge of the characteristics of ovarian cancer, chemoresistance is still an enormous clinical challenge. Current research suggests that ovarian cancer stem cells (OCSCs) might be involved in the occurrence of chemoresistance in ovarian cancer. In this review, we focus on the relationship of ovarian cancer stem cells with drug-resistant ovarian cancer phenotypes. We also discuss the current knowledge regarding ovarian cancer stem cell-based therapeutic strategies as attempts to overcome chemoresistance, the largest obstacle for successful treatment. Finally, we discuss methods for improving the treatment outcomes of ovarian cancer patients with chemoresistance.

引用

页码：270 / 278

页数：9

共 50 条

[31] Ovarian cancer stem cells
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1152 - 1152
[32] Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance
Zhang, Wenjing
Torres-Rojas, Carolina
Yue, Junming
Zhu, Bing-Mei
EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (16) : 1810 - 1815
[33] Validation of potential chemoresistance markers in ovarian cancer by IHC
Popa, I
L'Esperance, S
Bachvarova, M
Tetu, B
Bachvarov, D
LABORATORY INVESTIGATION, 2006, 86 : 193A - 193A
[34] The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance
Kielbik, Michal
Szulc-Kielbik, Izabela
Klink, Magdalena
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
[35] Validation of potential chemoresistance markers in ovarian cancer by IHC
Popa, I
L'Esperance, S
Bachvarova, M
Tetu, B
Bachvarov, D
MODERN PATHOLOGY, 2006, 19 : 193A - 193A
[36] Screening of novel therapeutic markers for ovarian cancer stem cells
Choi, Dong Kyu
Min, Sang Hyun
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[37] Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
Krolewska-Daszczynska, Patrycja
Wendlocha, Dominika
Smycz-Kubanska, Marta
Stepien, Sebastian
Mielczarek-Palacz, Aleksandra
ONCOLOGY LETTERS, 2022, 24 (06)
[38] The therapeutic potential of stem cells for ovarian rejuvenation
Seli, E.
HUMAN REPRODUCTION, 2024, 39 : I92 - I92
[39] The role of TWIST1 in chemoresistance and metastasis in ovarian cancer - potential therapeutic applications
Roberts, Cai
Han, Ernest S.
Lowe, Gina
Finlay, James
Wilczynski, Sharon
Ghoda, Lucy
Glackin, Carlotta
Dellinger, Thanh H.
CLINICAL CANCER RESEARCH, 2013, 19
[40] Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)
Niiro, Emiko
Morioka, Sachiko
Iwai, Kana
Yamada, Yuki
Ogawa, Kenji
Kawahara, Naoki
Kobayashi, Hiroshi
BIOMEDICAL REPORTS, 2018, 8 (03) : 215 - 223

← 1 2 3 4 5 →